Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/22/2012EP1715042B1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
08/22/2012EP1649028B1 Adenoviral vector-based vaccines
08/22/2012EP1597400B1 Methods of producing influenza vaccine compositions
08/22/2012EP1383796B2 Neurovirulent strain of the west nile virus and applications thereof
08/22/2012CN1997741B Novel mite allergen
08/22/2012CN1934248B HBV variants detection and application
08/22/2012CN1918178B Fc region variants
08/22/2012CN1909918B T cell immunoreaction inhibitor
08/22/2012CN1865281B Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
08/22/2012CN1622815B Immune stimulating substance including methane nutrition bacteria biomass
08/22/2012CN1592720B Metal binding proteins and associated methods
08/22/2012CN1449825B Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
08/22/2012CN1449293B Multivalent vaccine composition
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648209A Enhanced malaria MSP-1 subunit vaccine
08/22/2012CN102648003A Selectively disrupted whole-cell vaccine
08/22/2012CN102648002A IL-17 family cytokine compositions and uses
08/22/2012CN102648001A Adjuvanted vaccine formulations
08/22/2012CN102648000A Novel influenza virus
08/22/2012CN102647999A Compositions for immunising against staphylococcus aerus
08/22/2012CN102643822A Heartworm nucleic acid vaccine and method for preparing same
08/22/2012CN102643785A Method for targeted inhibition of infiltration and transfer of glioma cells and application of method
08/22/2012CN102643768A Vaccine for preventing chicken diseases and preparation method thereof
08/22/2012CN102643345A Bispecific anti-egfr/anti-igf-1r antibodies
08/22/2012CN102643344A Binding constructs and methods for use thereof
08/22/2012CN102643343A Human derived anti-rabies virus glycoprotein gene engineering antibody and preparation and application thereof
08/22/2012CN102643336A Avian chlamydophila psittaci outer membrane protein N-PmpD, preparation method and application
08/22/2012CN102643329A Functional epitopes of ricin, monoclonal antibodies specifically bound with functional epitopes and use thereof in preparation of medicaments for preventing or treating ricin poisoning
08/22/2012CN102641504A Heat-resistant freeze-drying protecting agent for vaccine and preparing method
08/22/2012CN102641500A Composite for preventing and curing diarrhea of piglets
08/22/2012CN102641499A Construction and application of recombinant Peste des petits ruminants virus (PPRV) live vector vaccine for foot and mouth disease virus (FMDV) VP1 gene
08/22/2012CN102641498A Preparation method for channel catfish intussusception duplex inactivated vaccine
08/22/2012CN102229915B EV71 virus monoclonal antibody, hybridoma cell line and application
08/22/2012CN102085367B Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating rheumatoid arthritis
08/22/2012CN102078609B Method for preparing duck virus hepatitis refined heterogenous yolk antibody
08/22/2012CN102038942B Method for industrially producing porcine reproductive and respiratory syndrome (PRRS) vaccines by utilizing bioreactor
08/22/2012CN101955917B Virus-like particle containing porcine parvovirus VP2 and somatostatin chimeric protein
08/22/2012CN101942419B Dog parvovirus attenuated vaccine strain and application thereof
08/22/2012CN101921726B Oral transformant for immunizing and blocking chicken inhibin and application thereof
08/22/2012CN101912608B Method for producing paratyphus living vaccine for piglets
08/22/2012CN101884788B Traditional Chinese medicine astragalus polysaccharide immunopotentiator
08/22/2012CN101687029B An hbv vaccine and a process of preparing the same
08/22/2012CN101622009B Influenza vaccine formulation
08/22/2012CN101574518B Hapten-carrier conjugates and uses thereof
08/22/2012CN101460518B Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
08/22/2012CN101365483B Adjuvanted influenza vaccines including cytokine-inducing agents
08/22/2012CN101342367B Edwardsiella tarda attenuated live vaccine
08/22/2012CN101166559B Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
08/22/2012CN101072580B Antibody production method
08/22/2012CN101063142B Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application
08/21/2012US8247537 Human monoclonal antibodies to BTLA and methods of use
08/21/2012US8247376 NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
08/21/2012US8247370 Conjoint therapy for treating fibrotic diseases
08/21/2012US8247231 Methods and compositions for producing antigenic responses
08/21/2012US8247225 DNA promoters and anthrax vaccines
08/21/2012US8247207 Refrigerator-temperature stable influenza vaccine compositions
08/21/2012US8247188 FAS binding antibodies
08/21/2012US8247185 Conformation specific antibodies
08/21/2012US8246966 Trypanosome microsome system and uses thereof
08/21/2012US8246965 Bacillus isolates and methods of their use to protect against plant pathogens
08/21/2012US8246964 Antigenic protein fragments of Streptococcus pneumoniae
08/21/2012US8246963 Vaccine for Edwardsiella disease and streptococcal disease in fish
08/21/2012US8246962 Canine influenza virus and vaccine therefore
08/21/2012US8246960 Methods and compositions for generating bioactive assemblies of increased complexity and uses
08/21/2012US8246959 Dendritic cell-associated lectin-like molecules, compositions and methods of use
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012US8246957 Lupus antibodies for passive immunotherapy of HIV/AIDS
08/21/2012US8246956 Humanized anti-nerve growth factor antibodies
08/21/2012US8246955 Substance specific to human PD-1
08/21/2012US8246954 Methods of treating amyloidosis with humanized anti-beta-amyloid antibodies
08/21/2012US8246953 Compositions and methods for use for antibodies against sclerostin
08/21/2012US8246952 Method of increasing radiation sensitivity by inhibition of beta one integrin
08/21/2012US8246945 Methods and reagents for decreasing clinical reaction to allergy
08/21/2012US8246944 Immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs
08/21/2012CA2646574C Vaccine against mycoplasma and prrsv
08/21/2012CA2633413C Antibodies against tumor-associated antigenic target (tat) polypeptides
08/21/2012CA2579798C Interleukin-15 antagonist peptide
08/21/2012CA2535004C Topical veterinary compositions and methods for the treatment and prevention of infection
08/21/2012CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease
08/21/2012CA2522812C Hla-a2 tumor associated antigen peptides and compositions
08/21/2012CA2512847C Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide
08/21/2012CA2485587C Muteins of placental growth factor type 1, preparation method and application thereof
08/21/2012CA2483848C Antibody against human insulin-like growth factor
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2450206C Improved yield of chordopoxvirus by propagation at low temperature
08/21/2012CA2425358C A vaccine composition comprising qs21, mpl, a cpg oligonucleotide and a cancer antigen
08/21/2012CA2424400C Adaptation sites of prrsv
08/21/2012CA2364026C Anti-tnf.alpha. antibodies in therapy of asthma
08/21/2012CA2362830C Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/21/2012CA2209021C Bacterial and synthetic polysaccharides for the enhancement of general immunity
08/18/2012CA2768801A1 Generation of virus-like particles and use as panfilovirus vaccine
08/16/2012WO2012109673A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012WO2012109668A1 Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
08/16/2012WO2012109659A1 Hla-restricted, peptide-specific antigen binding proteins
08/16/2012WO2012109567A2 Treatment of angiogenesis disorders
08/16/2012WO2012109553A2 Ch2 domain template molecules derived from rational grafting of donor loops onto ch2 scaffolds
08/16/2012WO2012109404A1 Yeast-based therapeutic for chronic hepatitis b infection
08/16/2012WO2012109373A2 Treatment of osteoarthritis and pain
08/16/2012WO2012109285A2 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
08/16/2012WO2012109282A2 Methods and systems for treating or preventing pregnancy-related hypertensive disorders
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1823